2c. The changing landscape of Alzheimer's Disease
Track 3
| Thursday, November 21, 2024 |
| 11:35 AM - 12:35 PM |
| Riverside Theatre |
Details
60min clinical presentation | With the advent of disease-modifying medications for Alzheimer’s disease (AD) and commercial availability of clinically validated AD blood-based biomarkers (Meyer et al, 2024), there is a growing push to identify and treat Alzheimer’s disease as early as possible.
In this rapidly changing landscape, patients will look to their GP for security and guidance, and thus a clear understanding of the preclinical and prodromal stages of Alzheimer’s disease, the relevance of biomarker positivity and the efficacy of (and controversy surrounding) the disease-modifying medications is paramount.
Takeaways;
- Identify the association between the pathological changes and clinical stages of Alzheimer’s disease.
- Recognise mild cognitive impairment and people for whom biomarker testing is appropriate.
- Determine the ethical and practical implications of Alzheimer’s disease blood-based biomarker positivity.
In this rapidly changing landscape, patients will look to their GP for security and guidance, and thus a clear understanding of the preclinical and prodromal stages of Alzheimer’s disease, the relevance of biomarker positivity and the efficacy of (and controversy surrounding) the disease-modifying medications is paramount.
Takeaways;
- Identify the association between the pathological changes and clinical stages of Alzheimer’s disease.
- Recognise mild cognitive impairment and people for whom biomarker testing is appropriate.
- Determine the ethical and practical implications of Alzheimer’s disease blood-based biomarker positivity.
Speaker
Dr Stephanie Daly
Medical Educator
RACGP
The Changing Landscape of Alzheimer's Disease - Implications for Primary Care
Biography
Dr Rebecca Moore
GP
Dementia Training Australia
The Changing Landscape of Alzheimer's Disease - Implications for Primary Care
Biography
Dr Rebecca Moore is a GP in Newcastle with a special interest in geriatric medicine and a Masters degree in dementia. She has an active interest in dementia research and works as an educator with Dementia Training Australia.
